Unifab Pharmaceuticals Private Limited
About Unifab Pharmaceuticals Private Limited
Data last updated:
Unifab Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 August 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2016PTC285270. Its GSTIN is 27AABCU9957E1ZX (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Mohammad Gulam (Whole-Time Director) and Mohammed Asif Shaikh (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 9 Jay Residency Near Ram Rahim Nagar Gokhiware Thane 401202, Maharashtra, India – 401202.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.07 Lakh, a growth of 20% compared to the previous year. For the same year it recorded a net loss of ₹3.22 Lakh (net margin -105%) and EBITDA of -₹3.22 Lakh (EBITDA margin -105%). Revenue has declined at a compounded annual rate (CAGR) of 77% over three years and 62% over five years.
The company has about 2 employees on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Unifab Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No. 9 Jay Residency Near Ram Rahim Nagar Gokhiware Thane 401202, Maharashtra, India – 401202
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Unifab Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Unifab Pharmaceuticals Private Limited
FY 2025 filings availableUnifab Pharmaceuticals Private Limited reported revenue of ₹3.07 Lakh (up 20% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 20% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 62%. EBITDA rose 74% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3.22 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.22 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -105% | ||||
| Net Profit Margin | -105% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Unifab Pharmaceuticals Private Limited, buy the company report.
Board of directors of Unifab Pharmaceuticals Private Limited
Unifab Pharmaceuticals has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohammad Gulam Also directs: Golden Mist Pharmaceuticals Private Limited | Whole-Time Director | 01 Mar 2022 | 4 Years 8 Months | Current |
| Mohammed Asif Shaikh Also directs: Golden Mist Pharmaceuticals Private Limited | Whole-Time Director | 01 Mar 2022 | 4 Years 8 Months | Current |
| Majid Assim Shaikh | Director | 23 Jan 2021 | 5 Years 9 Months | Current |
Peer comparison
Unifab Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Heetul Graphics Pvt Ltd | ₹3.09 Lakh (FY 2025) | -73.0% | Anand, Gujarat, India | |||
| Vitmio Pharmaceuticals Private Limited | ₹3.09 Lakh (FY 2025) | Ambarnath, Maharashtra, India | ||||
| Cavalry Pharmaceuticals Private Limited | ₹3.08 Lakh (FY 2025) | -33.0% | Guwahati, Assam, India | |||
| Pelican Wellness Private Limited | ₹3.08 Lakh (FY 2025) | -3.0% | Ahmedabad, Gujarat, India | |||
| Doctmed Pharmaceutical Private Limited | ₹3.07 Lakh (FY 2024) | 9.0% | Gurgaon, Haryana, India | |||
| Unifab Pharmaceuticals Private Limitedthis company | ₹3.07 Lakh (FY 2025) | -₹3.22 Lakh | -105% | 20.0% | 2 | Thane, Maharashtra, India |
| Vetraise Nutrition Private Limited | ₹3.06 Lakh (FY 2024) | -92.0% | Chiraiya, Bihar, India | |||
| Exovate Pharmaceuticals & Medicament Private Limited | ₹3.06 Lakh (FY 2020) | Kalyanpur, Uttar Pradesh, India | ||||
| Arovid Pharmaceuticals Private Limited | ₹3.05 Lakh (FY 2020) | -15.0% | Varanasi, Uttar Pradesh, India | |||
| Hope-In Pharmaceuticals Private Limited | ₹3.03 Lakh (FY 2025) | 10.0% | Ropar, Punjab, India | |||
| Eleos Pharmaceuticals Private Limited | ₹3.03 Lakh (FY 2025) | 7.0% | Agra, Uttar Pradesh, India |
To see the full peer comparison of Unifab Pharmaceuticals Private Limited, buy the company report.
Auditor
Unifab Pharmaceuticals Private Limited is audited by SONGIRA & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SONGIRA & ASSOCIATES | FY 2019 | 128085W |
Shareholding
The shareholding of Unifab Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Unifab Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Unifab Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Unifab Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Unifab Pharmaceuticals Private Limited has a workforce of 2 employees on its EPFO records as of Apr 01, 2024, across 1 active EPFO establishment.
GST
Unifab Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCU9957E1ZX | Maharashtra | Active | 27 Dec 2017 |
To see the full GST registrations and return filing status of Unifab Pharmaceuticals Private Limited, buy the company report.
Recent activity
Unifab Pharmaceuticals Private Limited has 7 board changes on record since 2017: 3 appointments and 4 cessations. The latest: Smita Pillai ceased to be Director on 27 Mar 2022.
Frequently asked questions
Unifab Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 August 2016 (10+ years old) and is registered under CIN U74999MH2016PTC285270.
Unifab Pharmaceuticals has 3 current directors:
- Mohammad Gulam - Whole-Time Director
- Mohammed Asif Shaikh - Whole-Time Director
- Majid Assim Shaikh - Director
The latest financial statements of Unifab Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Unifab Pharmaceuticals is 27AABCU9957E1ZX, registered in Maharashtra.
The CIN (Corporate Identification Number) of Unifab Pharmaceuticals is U74999MH2016PTC285270. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Unifab Pharmaceuticals was incorporated on 29 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Unifab Pharmaceuticals by revenue are Heetul Graphics Pvt Ltd, Vitmio Pharmaceuticals Private Limited, Cavalry Pharmaceuticals Private Limited, Pelican Wellness Private Limited, Doctmed Pharmaceutical Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Smita Pillai ceased to be Director on 27 Mar 2022. Mohammad Gulam was appointed as Whole-Time Director on 01 Mar 2022. Mohammed Asif Shaikh was appointed as Whole-Time Director on 01 Mar 2022. Unifab Pharmaceuticals has 7 board changes on record in total.
The registered office of Unifab Pharmaceuticals is at Shop No. 9 Jay Residency Near Ram Rahim Nagar Gokhiware Thane 401202, Maharashtra, India – 401202.
Unifab Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Unifab Pharmaceuticals is compliant as of 07 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
